Atypical neuroleptic malignant syndrome associated with clozapine treatment

Neuropsychobiology

Volumn 35, Issue 4, 1997, Pages 197-199

  Amore, Mario ^a   Zazzeri, Nicoletta ^a   Berardi, Domenico ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Clozapine; Dopaminergic activity; Neuroleptic malignant syndrome

Indexed keywords

BENZODIAZEPINE; CLOZAPINE; NEUROLEPTIC AGENT; TRICYCLIC ANTIDEPRESSANT AGENT;

AGED; ARTICLE; CASE REPORT; DIFFERENTIAL DIAGNOSIS; FEMALE; FEVER; HUMAN; MANIC DEPRESSIVE PSYCHOSIS; NEUROLEPTIC MALIGNANT SYNDROME; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

AGED; CLOZAPINE; FEMALE; HUMANS; NEUROLEPTIC MALIGNANT SYNDROME;

EID: 0031006121     PISSN: 0302282X     EISSN: 14230224     Source Type: Journal    
DOI: 10.1159/000119344     Document Type: Article

References (21)

1. Shalev A, Munitz H: The neuroleptic malignant syndrome: agent and host interaction, Acta Psychiatr Scand 1986;73:337-347.
2. Levenson JL: Neuroleptic malignant syndrome, Am J Psychiatry 1985; 142:1137-1145.
3. Caroff SN: The neuroleptic malignant syndrome, J Clin Psychiatry 1980;41:79-83.
4. Keck PE Jr., Sebastianelli J, Pope HG Jr: Frequency and presentation of neuroleptic malignant syndrome in a stale psychiatric hospital, J Clin Psychiatry 1989:50:352-355.
5. Keck PE Jr., Carot TSN, McElrov SL: Neuroleptic malignant syndrome, End of a controversy? J Neuropsychiatry Clin Neurosci 1995;7:135-144.
6. Rosebush P, Stewart T: A prospective analysis of 24 episodes of neuroleptic malignant syndrome, Am J Psychiatry 1989;146:717-725.
7. Henderson VW, Wooten GF: Neuroleptic malignant syndrome: A pathogenetic role for dopamine receptor blockade? Neurology 1981;31: 132-137.
8. Friedman JH, Feinberg SS, Feldman RG: A neuroleptic malignant-like syndrome due to L-dopa withdrawal, Ann Neurol 1984; 16:126-127.
9. Simpson DM, David GC: Case report of neuroleptic malignant syndrome associated with withdrawal from amantadine, Am J Psychiatry 1984;141:796-797.
10. Hirsehom KA, Greenberg HS: Successful treatment oflevodopa induced myoclonus and levo-dopa withdrawal-induced neuroleptic malignant syndrome: A case report, Clin Neurophar-macol 1988;11:278-281.
11. Stennberg DE: Neuroleptic malignant syndrome: the pendulum swings, Am J Psychiatry 1986;143:1273-1275.
12. Abbott RJ, Loizou LA: Neuroleptic malignant syndrome, Br J Psychiatry 1986:148:47-51.
13. Tsai G, Crisostomo G, Rosenblatt ML, Stem TA: Neuroleptic malignant syndrome associated with clozapine treatment, Ann Clin Psychiatry 1995;7:91-95.
14. Kane J, Honigfeld G, Singer J: Clozapine for the treatment-resistant schizophrenic, Arch Gen Psychiatry 1988;45:789-796.
15. Miller D, Sharafuddin M, Kathol R: A case of clozapine-induced neuroleptic malignant syndrome, J Clin Psychiatry 1991;52:99-101.
16. Pope H, Cole J, Choras P, Fulwiler C: Apparent neuroleptic malignant syndrome with clozapine and lithium, J Nerv Menl Dis 1986:174: 493-495.
17. Nopoulos P, Flaum M, Miller DD: Atypical neuroleptic malignant syndrome (NMS) with an atypical neuroleptic: Clozapine-induced NMS without rigidity, Ann Clin Psychiatry 1990;2:251-253.
18. Goatcs MG, Escobar JI: An apparent neuroleptic malignant syndrome without extrapyrami-dal symptoms upon initiation of clozapine therapy: Report of a case and results of a clozapine rechallenge, J Clin Psychopharmacol 1992;12:139-140.
19. Reddig S, Minnema AM, Tandon R: Neuroleptic malignant syndrome and clozapine, Ann Clin Psychiatry 1993;5:25-27.
20. Misiaszek JJ, Potter RL: Atypical neuroleptic malignant syndrome responsive to conservative management, Psychosomatics I985;26: 62-66.
21. Marder SR: Adverse effects of clozapine, J Clin Psychiatry Monogr 1996; 14:11 -14.